StockNews.AI
DXCM
StockNews.AI
1 min

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DexCom, Inc. - DXCM

1. Pomerantz LLP investigates claims on behalf of DexCom investors. 2. Claims include securities fraud and unlawful business practices by DexCom officers. 3. Hunterbrook Media reported unauthorized design changes in G7 glucose monitoring system. 4. Inaccurate G7 readings allegedly led to hospitalizations and fatalities. 5. DexCom's stock fell 11.76% post-report publication.

4m saved
Insight
Article

FAQ

Why Very Bearish?

The allegations of fraud and safety issues directly undermine investor confidence, akin to previous cases like Theranos.

How important is it?

The allegations could significantly impact DXCM's reputation and investor trust, critical for market performance.

Why Short Term?

Immediate investor reaction is likely, as seen with past stock price drops in similar controversies.

Related Companies

TMRCNVCRABT
, /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  DexCom, Inc. ("DexCom" or the "Company") (NASDAQ: DXCM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether DexCom and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On September 18, 2025, Hunterbrook Media ("Hunterbrook") published a short report entitled "Dexcom's Fatal Flaws".  The Hunterbrook report alleged, among other things, that Dexcom "made an unauthorized design change to a key component of the G7", the Company's continuous glucose monitoring system for diabetes management, and that "G7 users have been hospitalized and died" following inaccurate glucose readings from G7 devices.  On this news, Dexcom's stock price fell $8.99 per share, or 11.76%, over the following two trading sessions, to close at $67.45 per share on September 19, 2025. Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com. Attorney advertising. Prior results do not guarantee similar outcomes.   CONTACT:Danielle PeytonPomerantz LLP[email protected]646-581-9980 ext. 7980 SOURCE Pomerantz LLP WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News